Keep checking for updates and new content.

July 2017 Awareness Night Partial gland ablation for localized prostate cancer: Who is eligible and what are the risks? Dr. Nathan Perlis, MD, MSc, FRCSC Clinical assistant, Division of Urology, University Health Network Clinical fellow, Society of Urological Oncology, University of Toronto     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation […]

{ 0 comments }

From a conference in May 2017, a comprehensive overview of active surveillance by one of the experts in the field. View video.

{ 0 comments }

Video: Naturopathic Approaches to Prostate Cancer and Prostate Health

July 6, 2017

May 2017 Awareness Night Naturopathic Approaches to Prostate Cancer and Prostate Health Dr. Jeff Appelmann, BSc, ND Naturopathic Doctor/Clinic Director Canadian Naturopathic Cancer Clinic     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 53:57 minutes

Read the article or watch the video →

Newsletter July 2017

July 4, 2017

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Another fabulous  “Do it for dads” Walk Run! – complete with photos May Awareness Night: Dr. Jeff Appelmann: Naturopathic Approaches to Prostate Cancer and Prostate Health – Vidoe coming soon Volunteer Dinner at the Mandarin In Memoriam update July Awareness […]

Read the article or watch the video →

Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival

July 2, 2017

Adding abiraterone acetate (Zytiga) plus prednisone to standard hormonal therapy for men newly diagnosed with high-risk, metastatic prostate cancer lowers the chance of death by 38%. In a phase III clinical trial of 1,200 men, abiraterone also more than doubled the median time until the cancer worsened, from 14.8 months to 33 months. Read the […]

Read the article or watch the video →

New IsoPSA assay detects prostate cancer more precisely than current tests

July 2, 2017

A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read […]

Read the article or watch the video →

Immunotherapy

July 2, 2017

Immunotherapy is an exciting new field of study that is designed to boost the body’s immune system to fight cancer. It uses materials either made by the body or in a lab to improve, target or restore immune function. There are different types of immunotherapy including vaccines, monoclonal antibodies and non-specific immunotherapies. In prostate cancer, […]

Read the article or watch the video →

Cholesterol Linked to High-Grade Prostate Cancer

July 2, 2017

Elevated cholesterol levels are associated with an increased risk of high-grade prostate cancer, investigators reported at the American Urological Association 2017 annual meeting. Read the article here.

Read the article or watch the video →

Thousands of men with prostate cancer get risky treatment they don’t need.

July 2, 2017

Researchers are developing genetic tests, imaging tests, and algorithms like those in face-recognition software in an effort to reduce the 1 million US men a year who have prostate biopsies and, even more important, reduce the thousands who get treatment they don’t need. Read the article here.

Read the article or watch the video →

Single-fraction, high-dose brachytherapy may be viable for localized prostate cancer

July 2, 2017

Single-fraction 19 Gy high dose–rate brachytherapy may be a safe and effective treatment alternative for men with localized prostate cancer, according to study results. Read the article here.

Read the article or watch the video →